Sep
9
Las Vegas, NV – 09 September, 2014– (TechSonian) – RXi Pharmaceuticals Corp (NASDAQ:RXII) annunciated that a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company’s President CEO, Dr. Geert Cauwenbergh, will present at the Rodman Renshaw 16th Annual Global Investment Conference on Wednesday, September 10, 2014 at 12:05 p.m. EST.
RXi Pharmaceuticals Corp (NASDAQ:RXII) added 8.11%, trading on 831,054.00 shares, to end the trade at $3.60. The stock changed hands in a range of $3.33 – $3.72, bringing its market capitalization to about $53.62 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $2.21 on and was moved to the maximum level of $6.84.
Why Should Investors Buy RXII After The Recent Gain? Just Go Here and Find Out
Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) reported that Grupo Financiero Galicia S.A. operates as a financial services holding company in Argentina. The company operates through Banking, Regional Credit Cards, CFA Personal Loans, and Insurance segments.
Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) flopped -0.66%, to complete the trading session at $13.57, with a total volume of 830,447.00 shares. The stock, on average, trades on a volume of 883,073.00 shares. It floated in a range of $13.55 – $13.97 during the last trading session, with a beta value of 1.22. Its market capitalization now moved to about $2.01 billion. In the past 52 weeks, the share price has not declined below $6.93 and above $18.50.
Has GGAL Found The Bottom And Ready To Gain Momentum? Find Out Here
Lifelock Inc (NYSE:LOCK) apprise that Todd Davis, Chairman and Chief Executive Officer and Chris Power, Chief Financial Officer will be presenting , Credit Suisse Small/Mid Cap Conference in New York City, NY on Tuesday, September 16, 2014 at 8:50 a.m. EDT or 5:50 a.m. PDT.
Lifelock Inc (NYSE:LOCK) tumbled of -1.35% and was in a range of $15.23 – $15.71 before closing at $15.35. The stock completed the day with a total volume of 827,566.00 shares, versus an average volume of 1.03 million shares. The share price hit its 52-week low of $10.48 on May 20, 2014 and $22.85 was the best price in the same period.
Why Should Investors Buy LOCK After the Recent Fall? Just Go Here and Find Out
The Bank of Kentucky Financial Corp (NASDAQ:BKYF) posted that the investigation focuses on whether Bank of Kentucky’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of Bank of Kentucky’s shareholders.
The Bank of Kentucky Financial Corp (NASDAQ:BKYF) added 28.28% yesterday, bringing its market capitalization around $278.12 million. The share price, after opening at $46.21, made a high of $46.21 and hovered above $46.70 to end the day at $46.50. The total number of shares that changed hands during the session was 822,006.00 shares, as compared to average trading volume of 11,846.00 shares.
Will BKYF Continue To Move Higher? Find Out Here
Open all references in tabs: [1 – 5]
Comments
Leave a Reply
You must be logged in to post a comment.